Translational Endocrine tumor biology laboratory works on understanding the molecular basis of endocrine disorders particularly Pheochromocytomas and paragangliomas (PPGLs), MEN1 Syndrome and Parathyroid tumors through integrated genomics, proteomics, and metabolomics approaches. We aim to identify disease-causing genetic variants, characterize altered molecular pathways, and discover clinically relevant biomarkers for improved diagnosis, prognosis, and precision medicine in endocrine diseases.





